Champions Oncology vs 908 Devices
Champions Oncology and 908 Devices are similar in size: $59.4m and $56.2m of revenue in their latest fiscal years. 908 Devices grew faster (17.7% against 4.4%). 908 Devices kept more of each dollar of sales as profit: a net margin of 34.7% against -2.0%. Champions Oncology carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Champions OncologyCSBR, 2026 | 908 DevicesMASS, 2025 |
|---|---|---|
| Revenue | $59.4m | $56.2m |
| Revenue growth | 4.4% | 17.7% |
| Net income | −$1.2m | $19.5m |
| Operating margin | -1.9% | -70.1% |
| Net margin | -2.0% | 34.7% |
| Return on equity | -30.5% | 15.1% |
| Free cash flow | −$5.0m | −$24.6m |
| Cash | $4.9m | $70.5m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 214 | 172 |
| Market value | $67.6m | $403m |
| Price vs our value range | — | — |
| Moat score | 63 (Moderate) | 24 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 59 sales |